Corrigendum to "Immunological responses to pneumococcal vaccine in frail older people" [Vaccine 27 (2009) 1628-1636] (DOI:10.1016/j.vaccine.2008.11.098);Immunological responses to pneumococcal vaccine in frail older people

Vaccine

Volumn 27, Issue 10, 2009, Pages 1628-1636

  Ridda, I ^a,b   MacIntyre, C R ^d   Lindley, R ^b,c   Gao, Z ^d   Sullivan, J S ^e,f   Yuan, F F ^e,f   McIntyre, P B ^a  

^a National Centre for Immunization Research and Surveillance Sydney   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^f University of Sydney   (Australia)

Author keywords

Frail; Immune responses; Older people; Pneumococcal disease; Pneumococcal vaccines

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BARTHEL INDEX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRAIL ELDERLY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; VACCINATION;

EID: 60349113903     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.001     Document Type: Erratum

References (43)

1. Australian Bureau of Statistics. Population Projections Australia 2002-2100;2003.
2. Prevention of pneumococcal disease. MMWR 46 (1977) 1-24
3. Fedson D.S., and Scott J.A. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 17 (1999) S11-S18
4. Cartwright K. Pneumococcal disease in Western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr 161 April (4) (2002) 188-195 (0340-6199-1432-1076 (Online))
5. Kovaiou R.D., Herndler-Brandstetter D., and Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med 9 3 (2007) 1-17
6. Jackson L.A., Neuzil K.M., Yu O., Benson P., Barlow W., Adams A., et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 348 May (18) (2003) 1747-1755
7. Vila-Corcoles A., Ochoa-Gondar O., Hospital I., Ansa X., Vilanova A., Rodriquez T., et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 43 7 (2006) 860-868 [see comment]
8. Ansaldi F., Turello V., Lai P., Bastone G., De Luca S., Rosselli R., et al. Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res 33 Sep (5) (2005) 490-500
9. Douglas R.M., and Miles H.B. Vaccination against streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children. J Infect Dis 149 6 (1984) 861-869
10. Karma P., Luotonen J., Timonen M., Pontynen S., Pukander J., Herva E., et al. Efficacy of pneumococcal vaccination against recurrent otitis media. Preliminary results of a field trial in Finland. Ann Otol Rhinol Laryngol 89 May (3:Pt 2) (1980) [Supplement] t-62
11. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 3 (2000) 187-195
12. Jackson L.A., Neuzil K.M., Nahm M.H., Whitney C.G., Yu O., Nelson J.C., et al. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 25 May (20) (2007) 4029-4037
13. Ortqvist A., Hedlund J., and Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Resp Crit Care Med 26 December (6) (2005) 563-574 [Review] [140 refs]
14. Artz A.S., Ershler W.B., and Longo D.L. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev 16 April (2) (2003) 308-318
15. Bortz W.M. A conceptual framework of frailty: a review. J Gerontol A: Biol Sci Med Sci 57 May (5) (2002) M283-M288
16. Fried L.P., Ferrucci L., Darer J., Williamson J.D., and Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A: Biol Sci Med Sci 59 March (3) (2004) 255-263
17. Levers M.J., Estabrooks C.A., and Ross Kerr J.C. Factors contributing to frailty: literature review. J Adv Nurs 56 November (3) (2006 Nov) 282-291
18. Rockwood K. Frailty and its definition: a worthy challenge. J Am Geriatr Soc 53 June (6) (2005) 1069-1070
19. Rockwood K., Song X., MacKnight C., Berman H., Hogan D.B., McDowell I., et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 173 August (5) (2005) 489-495
20. Andrew M.K., and Rockwood K. Psychiatric illness in relation to frailty in community-dwelling elderly people without dementia: a report from the Canadian study of health and aging. Can J Aging 26 1 (2007) 33-38
21. Blaum C.S., Xue Q.L., Michelon E., Semba R.D., and Fried L.P. The association between obesity and the frailty syndrome in older women: the women's health and aging studies. J Am Geriatr Soc 53 June (6) (2005) 927-934
22. Klein B.E., Klein R., and Knudtson M.D. Frailty and age-related cataract. Ophthalmology 113 December (12) (2006) 2209-2212
23. Rockwood K., Mitnitski A., Song X., Steen B., and Skoog I. Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc 54 June (6) (2006) 975-979
24. Rockwood K., Mogilner A., and Mitnitski A. Changes with age in the distribution of a frailty index. Mech Ageing Dev 125 July (7) (2004) 517-519
25. Mitnitski A., Song X., Skoog I., Broe G.A., Cox J., Grunfeld E., et al. Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc 53 December (12) (2005) 2184-2189
26. The Department of Infrastructure Planning and Natural Resources. Health service profile. Population projection for SWAHS. Annual report. NSW Government. Accessed 2005.
27. Martinsson L., and Eksborg S. Activity Index-a complementary ADL scale to the Barthel Index in the acute stage in patients with severe stroke. Cerebrovasc Dis 22 4 (2006) 231-239
28. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 November (3) (1975) 189-198
29. Anonymous. Bacterial respiratory pathogen (2003), Reference Laboratory
30. Wernette C.M., Frasch C.E., and Madore D. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 10 July (4) (2003) 514-519
31. Anonymous. CDC ELISA Program. Centers for Disease Control 2003; Vol. 2004.
32. Go E.S., and Ballas Z.K. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol 98 1 (1996) 205-215
33. Pneumococcal antibody testing. IBT Laboratories; 2008 [cited April 28, 2008].
34. Ridda I., MacIntyre R.C., Lindley R.I., McIntyre P.B., Sullivan J., Gilbert G., et al. Predictors of pneumococcal vaccination uptake in hospitalized patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Hum Vaccin 3 3 (2007) 83-86
35. Romero-Steiner S., Musher D.M., and Cetron M.S. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 29 2 (1999) 281-288
36. Rubins J.B., Puri A.K., and Loch J. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis 178 2 (1998) 431-440
37. Berk S.L., Verghese A., Berk M.L., Dison C., and Smith J.K. Survey of physician acceptance of the pneumococcal vaccine. South Med J 77 April (4) (1984) 450-454
38. Boom J.A., Nelson C.S., Laufman L.E., Kohrt A.E., and Kozinetz C.A. Improvement in provider immunization knowledge and behaviors following a peer education intervention. Clin Pediatr 46 (2007) 706-717
39. Fedson D.S. Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly. Clin Geriatr Med 8 1 (1992) 183-199
40. Goggins W.B., Woo J., Sham A., and Ho S.C. Frailty index as a measure of biological age in a Chinese population. J Gerontol A: Biol Sci Med Sci 60 August (8) (2005) 1046-1051
41. Woo J., Goggins W., Sham A., and Ho S. Public health significance of the frailty index. Disabil Rehabil 28 8 (2006) 515-521
42. Jones D.M., Song X., and Rockwood K. Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc 52 11 (2004) 1929-1933
43. Kulminski A., Yashin A., Arbeev K., Akushevich I., Ukraintseva S., Land K., et al. Cumulative index of health disorders as an indicator of aging-associated processes in the elderly: results from analyses of the National Long Term Care Survey. Mech Ageing Dev 128 March (3) (2007) 250-258